CXCR4 and neoplasm: The SDF-1/CXCR4 axis, a central regulator of MSC chemotaxis, can be pharmacologically inhibited by AMD3100, which has been shown to significantly impair MSC homing to tumors and subsequently delay tumor progression [104].